Northwest Biotherapeutics, Inc. (NWBO.OB) Makes National News with Approval of US Patent
One company that has been garnering major attention of late is the Maryland company Northwest Biotherapeutics. A state-of-the-art biotechnology company, the young company’s main focus is on developing immunotherapy products that treat cancers more efficiently than current treatments. With that plan in place, Northwest Biotherapeutics has started to turn heads in the field of cancer treatment. Today, Northwest Bio. announced that the US Patent and Trademark Office has allowed the company’s patent application on a system for automation of the initial stages of the manufacture of their DCVAX therapeutic cancer vaccines. The current first generation manufacturing is highly precise and…